Philipp Harter

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 24

Top Topics

Newly Diagnosed

Metastatic Colorectal Cancer

Top Venues

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Journal of gynecologic oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Domenica Lorusso, Marie-Ange Mouret-Reynier, Philipp Harter, Claire Cropet, Cristina Caballero, Pia Wolfrum-Ristau, Toyomi Satoh, Ignace Vergote, Gabriella Parma, Trine J Nøttrup, Coriolan Lebreton, Peter A Fasching, Carmela Pisano, Luis Manso, Hugues Bourgeois, Ingo Runnebaum, Claudio Zamagni, Anne-Claire Hardy-Bessard, Andreas Schnelzer, Michel Fabbro, Barbara Schmalfeldt, Dominique Berton, Antje Belau, Jean-Pierre Lotz, Martina Gropp-Meier, Laurence Gladieff, Hans-Joachim Lück, Sophie Abadie-Lacourtoisie, Eric Pujade-Lauraine, Isabelle L Ray-Coquard
Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (4) (2024)
Domenica Lorusso, Marie-Ange Mouret-Reynier, Philipp Harter, Claire Cropet, Cristina Caballero, Pia Wolfrum-Ristau, Toyomi Satoh, Ignace Vergote, Gabriella Parma, Trine J Nøttrup, Coriolan Lebreton, Peter A Fasching, Carmela Pisano, Luis Manso, Hugues Bourgeois, Ingo Runnebaum, Claudio Zamagni, Anne-Claire Hardy-Bessard, Andreas Schnelzer, Michel Fabbro, Barbara Schmalfeldt, Dominique Berton, Antje Belau, Jean-Pierre Lotz, Martina Gropp-Meier, Laurence Gladieff, Hans-Joachim Lück, Sophie Abadie-Lacourtoisie, Eric Pujade-Lauraine, Isabelle L Ray-Coquard
Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (4) (2024)
Domenica Lorusso, Marie-Ange Mouret-Reynier, Philipp Harter, Claire Cropet, Cristina Caballero, Pia Wolfrum-Ristau, Toyomi Satoh, Ignace Vergote, Gabriella Parma, Trine J Nøttrup, Coriolan Lebreton, Peter A Fasching, Carmela Pisano, Luis Manso, Hugues Bourgeois, Ingo Runnebaum, Claudio Zamagni, Anne-Claire Hardy-Bessard, Andreas Schnelzer, Michel Fabbro, Barbara Schmalfeldt, Dominique Berton, Antje Belau, Jean-Pierre Lotz, Martina Gropp-Meier, Laurence Gladieff, Hans-Joachim Lück, Sophie Abadie-Lacourtoisie, Eric Pujade-Lauraine, Isabelle L Ray-Coquard
Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (4) (2024)
Helmut Plett, Enzo Ricciardi, Vlad Vacaru, Jan Philipp Ramspott, Nicoletta Colombo, Jalid Sehouli, Andreas du Bois, Annalisa Garbi, Rolf Richter, Beyhan Ataseven, Giovanni Aletti, Elena Braicu, Florian Heitz, Rosalba Portuesi, Mustafa Zelal Muallem, Timoleon Dagres, Gabriella Parma, Eva Roser, Alexander Traut, Francesco Multinu, Philipp Harter
Adult ovarian granulosa cell tumors: analysis of outcomes and risk factors for recurrence. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
Helmut Plett, Enzo Ricciardi, Vlad Vacaru, Jan Phillip Ramspott, Nicoletta Colombo, Jalid Sehouli, Andreas du Bois, Annalisa Garbi, Rolf Richter, Beyhan Ataseven, Giovanni Aletti, Elena Braicu, Florian Heitz, Rosalba Portuesi, Mustafa Zelal Muallem, Timoleon Dagres, Gabriella Parma, Eva Roser, Alexander Traut, Francesco Multinu, Philipp Harter
Adult ovarian granulosa cell tumors: analysis of outcomes and risk factors for recurrence. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
Eva Maria Willing, Claudia Vollbrecht, Christine Vössing, Peggy Weist, Simon Schallenberg, Johanna M Herbst, Stefanie Schatz, Balázs Jóri, Guillaume Bataillon, Philipp Harter, Vanda Salutari, Antonio Gonzáles Martin, Ignace Vergote, Nicoletta Colombo, Julia Roeper, Tobias Berg, Regina Berger, Bettina Kah, Trine Jakobi Noettrup, Markus Falk, Kathrin Arndt, Andreas Polten, Isabelle L Ray-Coquard, Franziska Selzam, Judith Pirngruber, Stefanie Schmidt, Michael Hummel, Markus Tiemann, David Horst, Jalid Sehouli, Eric Pujade-Lauraine, Katharina Tiemann, Elena Ioana Braicu, Lukas C Heukamp
Development of the NOGGO GIS v1 Assay, a Comprehensive Hybrid-Capture-Based NGS Assay for Therapeutic Stratification of Homologous Repair Deficiency Driven Tumors and Clinical Validation. Cancers 15 (13) (2023)
Karolin Heinze, Evan S Cairns, Shelby Thornton, Bronwyn Harris, Katy Milne, Marcel Grube, Charlotte Meyer, Anthony N Karnezis, Sian Fereday, Dale W Garsed, Samuel C Y Leung, Derek S Chiu, Malak Moubarak, Philipp Harter, Florian Heitz, Jessica Nell McAlpine, Anna De Fazio, David D L Bowtell, Ellen L Goode, Malcolm C Pike, Susan J Ramus, Celeste Leigh Pearce, Annette Staebler, Martin Koebel, Stefan Kommoss, Aline Talhouk, Brad H Nelson, Michael S Anglesio
The prognostic effect of immune cell infiltration depends on molecular subtype in Endometrioid Ovarian Carcinomas. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Majdi Imterat, Philipp Harter, Kerstin Rhiem, Florian Heitz, Stephanie Schneider, Nicole Concin, Malak Moubarak, Julia Welz, Vasileios Vrentas, Alexander Traut, Eric Hahnen, Rita Schmutzler, Andreas du Bois, Beyhan Ataseven
Incidence and Prognostic Impact of Deleterious Germline Mutations in Primary Advanced Ovarian Carcinoma Patients. Cancers 15 (9) (2023)
Melisa Guelhan Inci, Jalid Sehouli, Eva Schnura, Marlene Lee, Stephanie Roll, Thomas Reinhold, Julia Klews, Lutz Kaufner, Phil Niggemann, Harald Groeben, Julia Toelkes, Anett Reisshauer, Max Liebl, Enrico Daehnert, Manuela Zimmermann, Barbora Knappe-Drzikova, Susanne Rolker, Björn Nunier, Engi Algharably, Adak Pirmorady Sehouli, Lena Zwantleitner, Andrea Krull, Florian Heitz, Beyhan Ataseven, Radoslav Chekerov, Philipp Harter, Stephanie Schneider
The KORE-INNOVATION trial, a prospective controlled multi-site clinical study to implement and assess the effects of an innovative peri-operative care pathway for patients with ovarian cancer: rationale, methods and trial design. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
Florian Heitz, Christian Marth, Stéphanie Henry, Alexander Reuss, David Cibula, Lydia Gaba Garcia, Nicoletta Colombo, Barbara Schmalfeld, Nikolaus de Gregorio, Pauline Wimberger, Annette Hasenburg, Jalid Sehouli, Martina Gropp-Meier, Philip C Schouten, Eric Hahnen, Jan Hauke, Sandra Polleis, Philipp Harter
AGO-OVAR 28/ENGOT-ov57. Niraparib alone versus niraparib in combination with bevacizumab in patients with carboplatin-taxane-based chemotherapy in advanced ovarian cancer: a multicenter randomized phase III trial. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
Ursula A Matulonis, Domenica Lorusso, Ana Oaknin, Sandro Pignata, Andrew Dean, Hannelore G Denys, Nicoletta Colombo, Toon Van Gorp, Jason A Konner, Margarita Romeo Marin, Philipp Harter, Conleth G Murphy, Jiuzhou Wang, Elizabeth Noble, Brooke Esteves, Michael Method, Robert L Coleman
Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Majdi Imterat, Philipp Harter, Kerstin Rhiem, Florian Heitz, Stephanie Schneider, Nicole Concin, Malak Moubarak, Julia Welz, Vasileios Vrentas, Alexander Traut, Eric Hahnen, Rita Schmutzler, Andreas du Bois, Beyhan Ataseven
Incidence and Prognostic Impact of Deleterious Germline Mutations in Primary Advanced Ovarian Carcinoma Patients. Cancers 15 (9) (2023)
Domenica Lorusso, Marie-Ange Mouret-Reynier, Philipp Harter, Claire Cropet, Cristina Caballero, Pia Wolfrum-Ristau, Toyomi Satoh, Ignace Vergote, Gabriella Parma, Trine J Nøttrup, Coriolan Lebreton, Peter A Fasching, Carmela Pisano, Luis Manso, Hugues Bourgeois, Ingo Runnebaum, Claudio Zamagni, Anne-Claire Hardy-Bessard, Andreas Schnelzer, Michel Fabbro, Barbara Schmalfeldt, Dominique Berton, Antje Belau, Jean-Pierre Lotz, Martina Gropp-Meier, Laurence Gladieff, Hans-Joachim Lück, Sophie Abadie-Lacourtoisie, Eric Pujade-Lauraine, Isabelle L Ray-Coquard
Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
Ursula A Matulonis, Domenica Lorusso, Ana Oaknin, Sandro Pignata, Andrew Dean, Hannelore G Denys, Nicoletta Colombo, Toon Van Gorp, Jason A Konner, Margarita Romeo Marin, Philipp Harter, Conleth G Murphy, Jiuzhou Wang, Elizabeth Noble, Brooke Esteves, Michael Method, Robert L Coleman
Reply to Z.R. McCaw et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Konstantin Weber-Lassalle, Corinna Ernst, Alexander Reuss, Kathrin Möllenhoff, Klaus Baumann, Christian Jackisch, Jan Hauke, Dimo Dietrich, Julika Borde, Tjoung-Won Park-Simon, Lars C Hanker, Katharina Prieske, Sandra Schmidt, Nana Weber-Lassalle, Esther Pohl-Rescigno, Stefan Kommoss, Frederik Marmé, Florian Heitz, Julia Carolin Stingl, Rita K Schmutzler, Philipp Harter, Eric Hahnen
Clonal Hematopoiesis-Associated Gene Mutations in a Clinical Cohort of 448 Patients With Ovarian Cancer. Journal of the National Cancer Institute 114 (4) (2022)
Martina Aida Angeles, Nicolò Bizzarri, Alexander Shushkevich, Natalia R Gómez-Hidalgo, Charlampos Theofanakis, Aleksandra Strojna, Aleksandra Helena Symonides, Esra Bilir, Zoia Razumova, Andreas du Bois, David Cibula, Nicole Concin, Christina Fotopoulou, Alexandros Rodolakis, Philipp Harter, Pedro T Ramirez
Interviews from the European Society of Gynaecological Oncology 2021 Congress: an IJGC-ENYGO Fellows compilation. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 32 (4) (2022)
Jacobus Pfisterer, Florence Joly Lobbedez, Gunnar B Kristensen, Joern Rau, Sven Mahner, Patricia Pautier, Ahmed El-Balat, Jean-Emmanuel Kurtz, Ulrich Canzler, Jalid Sehouli, Martin L Heubner, Andreas D Hartkopf, Klaus Baumann, Annette Hasenburg, Lars C Hanker, Antje Belau, Barbara Schmalfeldt, Dominik Denschlag, Tjoung-Won Park-Simon, Frédéric Selle, Christian Jackisch, Alexander Burges, Hans-Joachim Lück, Günter Emons, Werner Meier, Martina Gropp-Meier, Willibald Schröder, Nikolaus de Gregorio, Felix Hilpert, Philipp Harter
Optimal Treatment Duration of Bevacizumab as Front-Line Therapy for Advanced Ovarian Cancer: AGO-OVAR 17 BOOST/GINECO OV118/ENGOT Ov-15 Open-Label Randomized Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Majdi Imterat, Philipp Harter
Early-stage epithelial ovarian cancer: is systematic lymph node staging mandatory? Journal of gynecologic oncology 32 (4) (2021)
Paul DiSilvestro, Nicoletta Colombo, Philipp Harter, Antonio González-Martín, Isabelle L Ray-Coquard, Robert L Coleman
Maintenance Treatment of Newly Diagnosed Advanced Ovarian Cancer: Time for a Paradigm Shift? Cancers 13 (22) (2021)
Keiichi Fujiwara, Hiroyuki Fujiwara, Hiroyuki Yoshida, Toyomi Satoh, Kan Yonemori, Shoji Nagao, Takashi Matsumoto, Hiroaki Kobayashi, Hughes Bourgeois, Philipp Harter, Anna Maria Mosconi, Isabel Palacio Vazquez, Reinthaller Alexander, Tomoko Fujita, Philip Rowe, Eric Pujade-Lauraine, Isabelle L Ray-Coquard
Olaparib plus bevacizumab as maintenance therapy in patients with newly diagnosed, advanced ovarian cancer: Japan subset from the PAOLA-1/ENGOT-ov25 trial. Journal of gynecologic oncology 32 (5) (2021)
Elena Ioana Braicu, Andreas du Bois, Jalid Sehouli, Julia Beck, Sonia Prader, Hagen Kulbe, Bernd Eiben, Philipp Harter, Alexander Traut, Klaus Pietzner, Ralf Glaubitz, Beyhan Ataseven, Radoslav Chekerov, Christoph Keck, Thomas Winkler, Sebastian Heikaus, Peggy Gellendin, Ekkehard Schütz, Florian Heitz
Cell-Free-DNA-Based Copy Number Index Score in Epithelial Ovarian Cancer-Impact for Diagnosis and Treatment Monitoring. Cancers 14 (1) (2021)
Liina Salminen, Elena Ioana Braicu, Mitja Lääperi, Antti Jylhä, Sinikka Oksa, Sakari Hietanen, Jalid Sehouli, Hagen Kulbe, Andreas du Bois, Sven Mahner, Philipp Harter, Olli Carpén, Kaisa Huhtinen, Johanna Hynninen, Mika Hilvo
A Novel Two-Lipid Signature Is a Strong and Independent Prognostic Factor in Ovarian Cancer. Cancers 13 (8) (2021)
Philipp Harter, Andreas du Bois, Jalid Sehouli, Sven Mahner, Ignace Vergote, Luis Chiva, Antonio Gonzalez-Martin, Christina Fotopoulou
Is there a role for HIPEC in ovarian cancer? Archives of gynecology and obstetrics 298 (5) (2019)
Philipp Harter, Jan Hauke, Florian Heitz, Alexander Reuss, Stefan Kommoss, Frederik Marmé, André Heimbach, Katharina Prieske, Lisa Richters, Alexander Burges, Guido Neidhardt, Nikolaus de Gregorio, Ahmed El-Balat, Felix Hilpert, Werner Meier, Rainer Kimmig, Karin Kast, Jalid Sehouli, Klaus Baumann, Christian Jackisch, Tjoung-Won Park-Simon, Lars Hanker, Sandra Kröber, Jacobus Pfisterer, Heidrun Gevensleben, Andreas Schnelzer, Dimo Dietrich, Tanja Neunhöffer, Mathias Krockenberger, Sara Y Brucker, Peter Nürnberg, Holger Thiele, Janine Altmüller, Josefin Lamla, Gabriele Elser, Andreas du Bois, Eric Hahnen, Rita Schmutzler
Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1). PloS one 12 (10) (2017)